UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 220

Sortiert nach

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

The New England journal of medicine, 2021-04, Vol.384 (13), p.1216-1226

2021

Link zum Volltext

Verfügbarkeit prüfen

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

The New England journal of medicine, 2019-10, Vol.381 (16), p.1547-1556

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope

Nature reviews. Nephrology, 2023-03, Vol.19 (3), p.194-211

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

Kidney international, 2022-03, Vol.101 (3), p.626-634

2022

Link zum Volltext

Verfügbarkeit prüfen

Racial Disparities in Access to and Outcomes of Kidney Transplantation in Children, Adolescents, and Young Adults: Results From the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European Renal Association−European Dialysis and Transplant Association) Registry

American journal of kidney diseases, 2016-02, Vol.67 (2), p.293-301

2016

Link zum Volltext

Verfügbarkeit prüfen

ESPN2021: Interactive hybrid—the future of medical congresses?

Pediatric nephrology (Berlin, West), 2022-04, Vol.37 (4), p.703-705

2022

Link zum Volltext

Verfügbarkeit prüfen

Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up

Kidney international, 2019-12, Vol.96 (6), p.1389-1399

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study

Nephrology, dialysis, transplantation, 2018-04, Vol.33 (4), p.552-560

2018

Link zum Volltext

Verfügbarkeit prüfen

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial

American journal of kidney diseases, 2023-02, Vol.81 (2), p.145-155.e1

2023

Link zum Volltext

Verfügbarkeit prüfen

A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3

Kidney international, 2021-09, Vol.100 (3), p.621-635

2021

Link zum Volltext

Verfügbarkeit prüfen

The appearance of oxalate crystals in a kidney biopsy is no proof of post-transplant oxalate nephropathy in primary hyperoxaluria type 1

Kidney international, 2022-08, Vol.102 (2), p.446-446

2022

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life in patients with pediatric onset of end-stage renal disease: state of the art and recommendations for clinical practice

Pediatric nephrology (Berlin, West), 2016-10, Vol.31 (10), p.1579-1591

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial

Clinical journal of the American Society of Nephrology, 2021-07, Vol.16 (7), p.1025-1036

2021

Link zum Volltext

Verfügbarkeit prüfen

Marked plaque regression in homozygous familial hypercholesterolemia

Atherosclerosis, 2021-06, Vol.327, p.13-17

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review

Journal of clinical lipidology, 2019-01, Vol.13 (1), p.31-39

2019

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy

Clinical journal of the American Society of Nephrology, 2012-03, Vol.7 (3), p.458-465

2012

Link zum Volltext

Verfügbarkeit prüfen

Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1

Kidney international, 2023-05, Vol.103 (5), p.990-993

2023

Link zum Volltext

Verfügbarkeit prüfen

Mortality risk in European children with end-stage renal disease on dialysis

Kidney international, 2016-06, Vol.89 (6), p.1355-1362

2016

Link zum Volltext

Verfügbarkeit prüfen

Office blood pressure versus ambulatory blood pressure measurement in childhood obesity

BMC pediatrics, 2023-04, Vol.23 (1), p.205-205, Article 205

2023

Link zum Volltext

Verfügbarkeit prüfen

Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy

Kidney international, 2023-07, Vol.104 (1), p.203-204

2023

Link zum Volltext

Verfügbarkeit prüfen

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (7), p.1773-1775

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope

Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

Racial Disparities in Access to and Outcomes of Kidney Transplantation in Children, Adolescents, and Young Adults: Results From the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European Renal Association−European Dialysis and Transplant Association) Registry

ESPN2021: Interactive hybrid—the future of medical congresses?

Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up

Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial

A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3

The appearance of oxalate crystals in a kidney biopsy is no proof of post-transplant oxalate nephropathy in primary hyperoxaluria type 1

Health-related quality of life in patients with pediatric onset of end-stage renal disease: state of the art and recommendations for clinical practice

Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry

Growth Patterns After Kidney Transplantation in European Children Over the Past 25 Years: An ESPN/ERA-EDTA Registry Study

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial

Marked plaque regression in homozygous familial hypercholesterolemia

Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis

Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review

The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results

Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy

Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1

Mortality risk in European children with end-stage renal disease on dialysis

Office blood pressure versus ambulatory blood pressure measurement in childhood obesity

Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1

Suchergebnisse filtern